Zydus receives final approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg

Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea

Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals

Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant

Nectar Lifesciences receives 7 observations from EDQM for API facility

The European regulator will conduct a re-inspection of the facility to verify the compliance

CCRH and Adamas University sign MoU to advance homoeopathy research

This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy

UFlex secures USFDA approval for recycled PE in food packaging

Announces Rs. 317 crore investment in new recycling plant

atulya celebrates International Women’s Day

Encourages working women to practice self-care

Indoco’s clinical research organisation ‘AnaCipher’ completes USFDA inspection

Fermenta's plant-based Vitamin D3 is 'Innovation of the Year'

VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals

Lupin Launches Rivaroxaban Tablets USP, 2.5mg in US

Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto® Tablets, 2.5 mg of Janssen Pharmaceuticals

Zydus Lifesciences launches ANVIMO

ANVIMO will be available in dosages of 240 mg and 480 mg